Hologen, a secretive AI startup co-founded by former Google CEO Eric Schmidt, is seeking to raise $150 million in a Series A fundraising round, STAT has learned.
Hologen describes itself as a “frontier medical AI company, a drug development & diagnostics company, and an investment company, wrapped into one,” according to a slide deck obtained by STAT. Spun out of University College London and King’s College London, Hologen has received seed money from family investment office SW7 as well as Schmidt. Materials accompanying the pitch deck indicated the round would allegedly be led by Averin and Atlas Venture, though Atlas partner Bruce Booth told STAT his firm isn’t involved in Hologen.
The company plans to build what it calls “large medicine models” that account for variation in different people’s biology and responses to treatment, which will “unmask true treatment effects in late-stage trials” and “de-risk billion-dollar clinical trials,” says the pitch deck.
